In a perspective piece in the New England Journal of Medicine, CP3 Director Walid Gellad and HPI Director Everette James describe the controversy surrounding the 340B Drug Pricing Program.Read more.
Prescribing habits following overdose
In a recent article in JAMA, researchers compared prescription opioid use and medication-assisted treatment rates before and after an overdose.
Accelerated Drug Approval
In a recent perspective piece in NEJM, Dr. Gellad discusses the accelerated approval process in the era of expensive drugs. Read more.
Addressing the Opioid Epidemic
In a commentary in JAMA Internal Medicine, Dr. Walid Gellad discusses the opioid epidemic within the Nation's Veteran population.
Drug Shortages in the US
Each year the United States experiences a shortage of over 100 drugs. In an editorial in JAMA, Drs. Donohue and Angus explore the reasons.
Safety Implications for Veterans
Expanding veterans' access to providers outside of the VA may increase the risk for unsafe prescribing practices, particularly in persons with dementia. Read more.
